淋巴瘤适应性辐射疗法:说明,早期经验和未来方向
Kiran A Kumar1, Xinran Zhong1, Zohaib Iqbal1
1Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas.
概括
适应性辐射疗法 (ART) 改善瘤向性,并减少淋巴瘤患者的治疗量. 这种技术允许更安全,更短的辐射课程,即使在具有挑战性的情况下.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 血液学 瘤学 癌症学
背景情况:
- 淋巴瘤是放射敏感的,可能存在于难以准的位置.
- 适应性辐射疗法 (ART) 通过允许较小的治疗量和适应瘤缩来提供潜在的好处.
研究的目的:
- 假设ART在各种淋巴瘤病例中可能有益.
- 描述早期的经验和概述在淋巴瘤中治疗ART的指示.
主要方法:
- 审查了使用圆束CT在线自适应RT (oART) 治疗的淋巴瘤患者的前性注册表.
- 根据淋巴瘤类型对患者进行分类,并分析了适应原因.
主要成果:
- 分析了67名患者的72个治疗疗程 (26个低级,46个高级淋巴瘤).
- 主要治疗oART的指示包括在移动位置更好的向 (69%),改变严重疾病 (69%) 和低分离 (38%).
- oART改善了计划目标体积 (PTV) 覆盖率,从72.2%降至95.2%,并在严重疾病病例中将PTV大小降低了24.6%.
结论:
- 在线适应性RT可以在各种淋巴瘤病例中成功实施.
- oART减少了治疗量,同时保持了PTV覆盖,使得辐射疗程更安全,更短.
- 需要进一步的研究来证实oART在淋巴瘤中的临床益处.
更多相关视频
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
14.8K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.2K
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
